Xanthelasma of eyelid

H7_XANTHELASMA

eyelid disease: A disease involving the eyelid.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H02.6 Cause of death: ICD-10 — H02.6 2 out of 7 registries used, show all original rules.	315
4. Check minimum number of events None	315
5. Include endpoints None	315
6. Filter based on genotype QC (FinnGen only)	315

Control definitions (FinnGen only)

Control exclude: H7_LIDLACRIMALORBIT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H02
Name in latin: Xanthelasma palpebrae

NAME	H7_XANTHELASMA
CONTROL_EXCLUDE	H7_LIDLACRIMALORBIT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H026
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H026
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Xanthelasma of eyelid based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2377	1690	683
Only index persons	2263	1624	639
Unadjusted period prevalence (%)
Whole population	0.04	0.05	0.02
Only index persons	0.05	0.06	0.02
Median age at first event (years)
Whole population	53.93	54.29	52.96
Only index persons	53.67	54.08	52.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	315	215	100
Unadjusted period prevalence (%)	0.06	0.07	0.04
Median age at first event (years)	54.15	54.02	54.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
288: Matched controls
2880

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02.6

ICD-10 Finland

Xanthelasma of eyelid

+∞

323.0

288

CBB30

NOMESCO Finland

Excision of lesion of eyelid

52.9

79.3

H02.3

ICD-10 Finland

Blepharochalasis

102.4

33.6

CBB99

NOMESCO Finland

Other excision or destruction of lesion of eyelid

284.5

26.1

ZXC10

NOMESCO Finland

Use of laser

12.8

15.9

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

30.5

15.4

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

+∞

14.7

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

+∞

13.6

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

+∞

11.5

H02.4

ICD-10 Finland

Ptosis of eyelid

36.6

11.4

ZXA10

NOMESCO Finland

Bilateral

2.8

9.9

310

H04.10

ICD-10 Finland

Dry eye syndrome

5.1

9.3

SPAT1153

SPAT

Removal of sutures

2.3

9.1

115

655

H02.1

ICD-10 Finland

Ectropion of eyelid

+∞

7.3

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

4.9

7.1

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

14.2

6.9

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

6.8

354

WX110

NOMESCO Finland

Local anesthesy

2.0

6.8

196

1497

C10AA05

ATC

atorvastatin; oral

2.0

6.7

121

776

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.3

6.4

335

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

6.4

221

J01AA02

ATC

doxycycline; systemic

2.1

6.2

232

1914

N07BA03

ATC

varenicline; oral

3.8

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

120

811

1.77

5.47

3.6

3.9

7.8

8.1

mg/mmol

0.03

516

(3037467) Urinalysis macro (dipstick) panel - Urine

220

1771

1.80

5.38

4.8

4.2

—

(42870588) Differential panel, method unspecified - Blood

118

830

1.67

4.48

6.3

5.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

189

1504

1.64

4.36

4.9

4.2

6.8

6.7

mmol/l

0.46

172

1408

(3012516) Albumin [Mass/volume] in Urine

110

766

1.67

4.31

3.0

3.2

48.3

214.7

mg/l

0.80

499

(3002030) Lymphocytes/100 leukocytes in Blood

158

1218

1.60

4.04

7.0

5.6

27.6

28.0

0.15

153

1139

(3009508) Creatinine [Moles/volume] in Urine

112

799

1.62

3.93

2.9

3.0

8.0

7.2

mmol/l

0.96

673

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

140

1054

1.59

3.93

2.2

2.0

94.9

98.4

pmol/l

0.36

525

(3032080) INR in Blood by Coagulation assay

138

1046

1.57

3.70

7.6

1.1

1.2

inr

0.84

312

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

241

2081

1.67

3.66

8.1

7.4

83.5

77.9

u/l

0.51

233

1940

(3013707) Erythrocyte sedimentation rate by Westergren method

232

1998

1.61

3.41

4.8

4.2

15.2

12.5

mm/h

1.81

223

1851

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

114

845

1.55

3.29

2.8

2.3

52.0

55.8

u/l

1.03

107

784

(3019198) Lymphocytes [#/volume] in Blood

162

1306

1.50

3.10

7.0

5.4

2.0

e9/l

0.05

150

1157

(40761511) CBC panel - Blood by Automated count

295

2739

2.21

3.08

16.2

12.9

—

(40768797) Stomach Pathology biopsy report

365

1.69

2.98

1.2

—

(3049717) Cytology report of Urine Cyto stain

2.30

2.97

2.0

2.8

—

(4094501)

2.51

2.93

1.0

1.1

—

(3001604) Monocytes [#/volume] in Blood

158

1277

1.48

2.93

6.8

5.4

0.7

0.6

e9/l

2.38

144

1098

(3013115) Eosinophils [#/volume] in Blood

163

1328

1.47

2.89

7.0

5.9

0.2

e9/l

0.32

151

1167

(3006315) Basophils [#/volume] in Blood

158

1280

1.47

2.88

6.9

5.4

0.0

e9/l

1.14

145

1103

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

284

2624

1.84

2.68

18.1

13.5

20.2

22.5

mg/l

0.73

246

2082

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

233

2053

1.52

2.68

4.9

4.0

14.9

14.8

pmol/l

0.08

219

1853

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

106

806

1.47

2.61

2.2

2.0

133.0

186.0

u/l

1.19

101

768

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

7.23

2.56

1.0

—

(3013512) EKG study

105

802

1.46

2.52

4.2

3.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

273

2506

1.67

2.49

7.3

5.9

41.1

39.9

mmol/mol

1.32

260

2337

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

125

992

1.43

2.43

3.9

3.7

39.7

33.4

ng/l

0.15

699

(3020564) Creatinine [Moles/volume] in Serum or Plasma

297

2798

2.08

2.42

20.6

16.1

75.2

74.7

umol/l

0.10

297

2798

(3007853) Bacteria identified in Skin by Aerobe culture

278

1.68

2.42

1.5

1.6

—

(3000492) Spirometry study

223

1.75

2.41

1.8

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

179

1517

1.42

2.39

9.2

9.5

4.5

4.0

e9/l

1.96

164

1330

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

390

1.56

2.29

2.0

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

159

1327

1.40

2.28

7.9

6.0

1.2

mmol/l

1.36

137

1126

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

267

2451

1.59

2.28

6.0

4.8

1.8

1.9

mu/l

0.45

250

2232

(3031040) Bacteria [#/volume] in Urine by Automated count

197

1717

1.39

2.13

4.9

4.3

222.3

265.7

e6/l

—

(3026008) Bacteria identified in Urine by Culture

103

807

1.41

2.10

3.6

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

280

2611

1.65

2.10

5.8

4.6

6.2

6.0

mmol/l

1.72

265

2397

(40758558) Short blood count panel - Blood

654

1.43

2.07

7.8

7.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.28

2.04

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

343

1.54

1.99

1.5

1.3

594.3

542.6

titre

0.08

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2.41

1.97

1.6

1.9

133.2

131.2

g/l

—

(3026782) Osmolality of Urine

478

1.45

1.86

3.1

2.7

563.1

552.6

mosm/kgh2o

0.11

416

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

778

1.38

1.82

2.6

3.1

1177.8

1363.7

ng/l

0.27

669

(3017732) Neutrophils [#/volume] in Blood

171

1.70

1.77

2.7

2.8

4.1

3.8

e9/l

0.27

133

(4010399)

195

1.65

1.76

1.5

1.4

—

(3018095) Leukocytes [#/volume] in Urine

112

914

1.35

1.74

3.9

3.6

46.3

72.4

e6/l

0.60

637

(3009261) Glucose [Presence] in Urine by Test strip

152

1299

1.33

1.72

4.2

3.6

0.0

estimate

0.00

235

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.69

1.5

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.69

1.5

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.62

1.67

2.3

1.5

—

(40768804) Tissue Pathology biopsy report

130

1091

1.33

1.66

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

113

1.82

1.64

10.7

8.2

—

(3023368) Bacteria identified in Blood by Culture

689

1.36

1.62

5.8

3.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.93

1.58

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.97

1.57

3.1

4.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

130

1099

1.31

1.55

2.5

2.3

76.4

77.1

nmol/l

0.12

122

976

(3044889) 12 lead EKG panel

210

1896

1.32

1.54

4.3

3.8

—

(3035350) Ketones [Presence] in Urine by Test strip

148

1275

1.30

1.53

4.1

3.6

0.0

estimate

0.00

248

(3023430) Cat dander IgE Ab [Units/volume] in Serum

3.37

1.53

1.0

1.1

—

2.1

—

(3017704) Immunofixation for Urine

3.37

1.53

1.2

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.11

1.51

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

304

1.48

1.51

1.8

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

716

1.34

1.49

3.9

3.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

383

1.43

1.48

1.6

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

148

1282

1.29

1.45

5.8

4.9

0.0

estimate

0.50

239

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

3.16

1.44

1.0

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

591

1.35

1.44

1.8

1.6

0.9

1.2

mg/l

0.72

471

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

284

2703

1.52

1.39

6.3

5.1

3.0

2.8

mmol/l

1.49

270

2490

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

2.64

1.37

2.8

2.2

3.3

nmol/l

—

(3000850) Epithelial cells [#/volume] in Urine

514

1.36

2.9

2.6

5.2

4.9

e6/l

0.10

459

(3019309) Folate [Moles/volume] in Red Blood Cells

487

1.37

1.36

1.7

1.8

919.6

1276.3

nmol/l

2.36

367

(3051611) Lipemic interference index of Serum or Plasma

2.97

1.36

4.0

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

277

1.47

1.35

2.2

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.76

1.30

7.6

5.1

1.4

1.6

0.46

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.76

1.30

7.6

5.1

1.0

0.9

0.61

(3014133) Dog dander IgE Ab [Units/volume] in Serum

2.81

1.29

1.0

1.1

—

0.5

—

(3021589) Normoblasts [#/volume] in Blood

136

1179

1.27

1.28

10.1

8.9

0.0

e9/l

0.55

123

958

(3022217) INR in Platelet poor plasma by Coagulation assay

333

1.41

1.26

22.3

1.3

inr

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

273

1.45

1.25

2.1

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

577

1.32

1.23

3.8

3.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

293

2818

1.57

1.23

12.7

10.4

26.0

25.6

u/l

0.20

287

2722

(3003396) Base excess in Arterial blood by calculation

275

1.43

1.21

7.4

6.9

0.5

1.5

mmol/l

1.06

218

(3007164) IgA [Mass/volume] in Serum or Plasma

488

1.34

1.20

1.6

1.5

2.8

2.5

g/l

0.40

294

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

138

1212

1.25

1.13

4.4

3.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.03

1.13

2.8

2.5

—

(3041354) Potassium [Moles/volume] in Venous blood

2.03

1.13

2.7

2.5

4.1

4.0

mmol/l

—

(3035285) Chloride [Moles/volume] in Venous blood

2.03

1.13

2.7

2.5

106.1

106.0

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

829

1.26

1.11

2.8

2.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

117

1011

1.25

1.11

4.4

3.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

136

1196

1.24

1.10

7.0

5.1

1.2

mmol/l

1.19

124

1088

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.40

1.09

1.6

2.3

13.2

13.4

—

(3002582) Erythrocytes [#/volume] in Urine

794

1.26

1.08

3.5

3.0

30.2

53.7

e6/l

0.75

590

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

277

2648

1.38

1.07

5.6

4.6

4.8

mmol/l

0.59

264

2455

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.15

1.06

1.0

1.7

—

(3000330) Specific gravity of Urine by Test strip

138

1.56

1.06

3.2

3.5

—

(3019150) Specific gravity of Urine by Refractometry

563

1.29

1.04

4.7

3.9

1.0

kg/l

0.04

(40760888) Immunoglobulin light chains.free panel - Serum

1.86

1.04

3.8

3.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.29

1.04

1.6

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.90

1.01

1.1

1.3

20.8

10.6

u/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.02

1.00

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

2.02

1.00

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

268

2556

1.33

1.00

5.0

4.1

1.3

mmol/l

0.41

248

2344

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.66

0.99

1.1

1.4

25.7

29.3

iu/l

0.18

(3021440) Promyelocytes/100 leukocytes in Blood

208

1.43

0.99

3.0

4.0

0.3

0.2

0.19

(3010726) Horse dander IgE Ab [Units/volume] in Serum

2.19

0.98

1.0

—

0.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.19

0.98

1.0

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

579

1.27

0.95

1.9

1.7

377.3

23554172.2

pmol/l

0.79

484

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

163

1477

1.21

0.95

2.8

2.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

108

940

1.23

0.94

3.7

3.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

479

1.29

0.93

4.2

3.7

59.2

329.2

ng/l

2.35

377

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.70

0.93

3.3

3.2

—

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

127

1.53

0.91

1.4

1.7

—

(3047181) Lactate [Moles/volume] in Blood

1.72

0.90

8.6

6.5

1.8

1.3

mmol/l

1.12

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

265

2533

1.29

0.89

16.5

12.6

79.8

79.1

ml/min/173m2

0.22

225

2115

(40761535) Cells panel - Urine sediment

227

0.64

0.88

5.1

3.2

—

(3044941) Cell count panel - Synovial fluid

1.84

0.86

1.5

1.7

—

(40768443) Skin Pathology biopsy report

104

1.57

0.86

1.3

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

606

1.24

0.85

2.4

2.1

3.1

3.2

mg/l

0.16

516

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.80

0.85

1.6

7.5

—

147.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.95

0.85

1.5

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.72

0.81

1.4

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

288

1.32

0.80

2.8

2.1

222.5

165.3

ug/g

0.20

234

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.79

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1.83

0.79

4.5

1.8

90.6

90.1

—

(21494434) Karyotype in Bone marrow

0.00

0.79

0.0

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.78

0.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

500

1.25

0.78

1.3

27.1

33.3

iu/ml

0.24

168

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.76

0.0

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.59

0.76

1.6

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

176

1.39

0.75

3.0

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

493

1.24

0.75

3.3

3.0

2.5

mmol/l

0.13

442

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

513

1.23

0.73

4.6

4.3

24.1

21.1

0.74

240

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.62

0.73

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.81

0.73

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.57

0.70

1.1

1.2

—

(3025159) Blasts/100 leukocytes in Blood

196

1.36

0.70

3.1

4.1

0.0

1.8

—

(3022621) pH of Urine by Test strip

170

1.38

0.70

3.0

2.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.68

0.69

3.0

3.1

4.7

4.8

e9/l

—

(3019225) pH of Specimen

269

1.30

0.67

3.9

3.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.64

0.67

3.3

3.1

58.0

61.7

—

(4306422)

1.80

0.66

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1.80

0.66

2.0

1.5

19.2

18.9

ug/l

—

(3017181) Myelocytes/100 leukocytes in Blood

225

1.32

0.66

3.0

3.9

0.7

1.3

0.74

(36304419) Bacteria [Presence] in Urine

690

1.19

0.65

3.7

2.8

—

(3021788) Differential panel - Synovial fluid

1.60

0.65

1.9

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

223

0.70

0.65

1.9

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

199

1.33

0.65

3.0

3.9

0.7

0.5

—

(3002032) Base excess in Venous blood by calculation

226

1.31

0.64

6.7

2.7

1.6

2.3

mmol/l

0.30

185

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.74

0.64

1.0

1.1

—

5.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.65

0.62

1.0

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

148

1.38

0.61

1.3

1.4

—

42.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

102

916

1.17

0.61

3.6

3.5

2.4

mmol/l

0.06

803

(3018572) Chloride [Moles/volume] in Blood

1.58

0.61

11.8

6.3

105.1

105.3

mmol/l

—

(3039000) Anion gap in Blood

1.58

0.61

11.6

6.3

11.4

11.0

mmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

272

2636

1.23

0.60

5.6

4.6

1.4

1.5

mmol/l

3.70

257

2433

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.60

0.0

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

1.55

0.60

3.4

2.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

19.6

—

1502.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

14.1

—

843.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.59

0.0

3.6

—

(36660697) Celiac disease serology panel - Serum

177

1.32

0.56

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.63

0.56

1.0

1.1

—

(3018418) pH of Serum or Plasma

816

1.16

0.55

5.2

3.7

7.4

0.42

152

(21494755) Public health laboratory ask at order entry panel

227

0.73

0.55

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.51

0.55

2.1

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.49

0.54

1.6

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.55

0.53

1.0

1.4

—

(3020891) Body temperature

100

0.59

0.52

3.2

4.3

—

(3012544) pH of Venous blood

235

1.26

0.50

6.7

2.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

699

1.15

0.48

2.5

2.6

312.6

7170.7

umol/l

3.05

593

(3021447) Carbon dioxide [Partial pressure] in Venous blood

228

1.25

0.47

6.9

2.7

6.0

5.8

kpa

0.44

222

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.44

0.46

1.0

1.4

223.8

293.5

ug/g

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

285

1.22

0.45

4.2

4.4

242.0

266.7

u/l

0.32

271

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

166

1.28

0.44

2.3

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

379

1.19

0.44

3.0

2.1

2.3

2.4

g/l

0.12

348

(3009542) Hematocrit [Volume Fraction] of Blood

242

2342

1.14

0.43

22.0

14.4

39.0

39.6

0.30

166

1659

(3023419) Bacteria identified in Sputum by Culture

1.62

0.43

10.8

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

344

1.19

0.41

4.8

4.6

31.7

31.9

0.05

230

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.1

—

(4027681)

0.00

0.41

0.0

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

1.37

0.41

2.1

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

215.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.41

0.0

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.48

0.40

1.0

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

411

1.17

0.40

3.2

2.7

2.9

3.3

e6/l

0.14

207

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

10.8

—

(3000991) Gas panel - Venous blood

188

1.24

0.38

11.3

6.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.37

0.38

1.3

2.2

189.7

193.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.34

0.38

1.1

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.33

0.38

3.1

2.8

1.9

1.5

mg/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

357

1.17

0.37

3.1

2.1

19.7

22.1

0.73

303

(3039443) Prostate specific Ag panel - Serum or Plasma

1.36

0.37

1.0

1.3

—

(3045424) Erythrocytes [Presence] in Urine

1.36

0.37

2.6

1.4

—

(3019060) Gas panel - Arterial blood

163

1.24

0.35

6.1

4.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

369

1.16

0.35

2.7

2.8

0.7

0.8

ug/l

0.43

243

(40761536) Microorganisms panel - Urine sediment

221

0.80

0.35

4.8

3.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

737

1.11

0.33

1.8

1.6

1.3

1.4

mmol/l

0.22

620

(3023183) Ammonium ion [Moles/volume] in Plasma

1.31

0.33

5.7

1.9

43.8

30.7

umol/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

631

1.12

0.32

1.7

1.5

20.4

21.0

nmol/l

0.12

526

(3003327) Ova and parasites identified in Stool by Light microscopy

1.34

0.32

1.2

1.5

—

(3022145) Colonoscopy Study observation

315

1.16

0.32

1.4

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

720

1.11

0.31

3.8

2.9

0.8

0.5

e6/l

0.53

519

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

153

0.78

0.31

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

228

0.82

0.30

2.3

2.6

82.9

65.8

ml/min/173m2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.30

0.30

2.1

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

106

0.75

0.29

2.9

1.9

5.3

1.4

ug/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.30

0.28

1.0

1.1

—

8.6

—

(3002256) Pathology report gross observation

348

1.14

0.27

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.24

0.27

1.0

1.3

—

(1002224) Polysomnography panel

113

1.25

0.27

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.22

0.27

1.9

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

151

1.20

0.25

1.9

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

468

1.11

0.23

1.3

23.9

9.1

u/ml

0.43

187

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.32

0.23

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

257

1.14

0.23

1.3

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.29

0.23

1.2

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.26

0.23

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

125

1.21

0.23

1.4

—

(1761868) Lipid panel - Serum or Plasma

971

0.93

0.22

3.9

3.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.22

0.22

1.2

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.21

0.0

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

4.1

—

13.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.21

0.0

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

43.2

—

(3028433) Virus identified in Specimen by Culture

0.00

0.21

0.0

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

30.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

443

1.10

0.20

3.1

2.6

1.0

1.2

e6/l

0.32

237

(3045414) Leukocytes [Presence] in Urine

108

1.21

0.20

2.5

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.20

0.0

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.20

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

1.16

0.19

6.8

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1.13

0.17

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1.23

0.17

1.6

2.3

12.9

12.5

mg/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.72

0.17

1.4

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.18

0.16

3.3

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.16

0.16

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.16

0.16

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.15

0.16

1.3

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

119

0.84

0.15

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

1.18

0.15

1.5

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.09

0.15

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

305

0.91

0.14

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

422

1.08

0.14

1.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.80

0.14

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

649

1.06

0.13

1.2

1.3

—

(3008898) HLA-B27 [Presence]

1.18

0.13

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

107

0.84

0.13

1.0

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

161

1.13

0.13

1.6

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

210

1.10

0.12

2.3

2.6

70.2

71.6

e9/l

0.06

165

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

333

0.92

0.12

5.5

7.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.17

0.11

2.1

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

713

1.05

0.11

5.2

3.8

0.0

estimate

0.50

239

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.14

0.10

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.14

0.10

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

2.0

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

145

0.89

0.09

1.5

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.04

0.09

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

1.04

0.09

1.8

2.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.82

0.08

1.8

2.5

7.7

8.0

kpa

—

(3027008) Opiates [Presence] in Urine

1.10

0.08

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1.10

0.08

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.03

0.08

1.3

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

274

1.06

0.07

2.6

3.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

177

1747

1.03

0.07

3.6

2.9

70.9

48.6

u/l

0.52

164

1633

(3017143) Hepatitis C virus Ab [Presence] in Serum

246

1.06

0.06

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

148

1.09

0.06

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

158

1.08

0.06

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

158

1.08

0.06

8.3

7.6

24.7

25.0

mmol/l

0.20

149

(3001122) Ferritin [Mass/volume] in Serum or Plasma

113

1111

1.03

0.06

3.2

2.6

109.2

123.0

ug/l

0.51

107

1018

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

267

1.05

0.05

1.5

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

594

1.03

0.05

4.9

4.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

556

1.03

0.04

1.4

1.2

1.4

1.5

u/ml

0.03

159

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

158

0.95

0.02

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

312

1.03

0.02

1.9

4.2

2.5

21.2

ug/l

0.79

262

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

613

1.01

0.01

3.1

2.1

—

(4035726)

264

1.02

0.00

1.3

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

132

0.98

0.00

2.4

2.3

—

(3022313) Gas panel - Capillary blood

121

0.99

0.00

1.6

3.0

—

(3025941) Bacteria identified in Stool by Culture

149

1.01

0.00

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

133

0.98

0.00

4.1

2.1

1.2

0.00

133

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

167

1.02

0.00

1.6

3.0

5.3

5.0

kpa

1.12

156

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

174

0.98

0.00

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

176

1.02

0.00

1.1

1.2

115.6

169.0

iu/ml

—

(3042936) Bacteria identified in Isolate by Culture

385

1.01

0.00

2.3

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

0.0

1.2

—

9.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.99

0.00

1.6

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3027944) Amphetamines [Presence] in Urine

0.95

0.00

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

1.8

—

(3001729) Color of Synovial fluid

0.00

0.0

1.4

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.02

0.00

1.6

2.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010421) pH of Blood

0.97

0.00

8.5

3.2

7.4

—

(3014051) Protein [Presence] in Urine by Test strip

1.00

0.00

2.8

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.96

0.00

1.1

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

21.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(40768446) Kidney Pathology biopsy report

0.00

0.0

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3016879) Cocaine [Presence] in Urine

1.02

0.00

1.5

1.3

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.89

0.00

1.8

1.6

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.02

0.00

1.6

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.0

1.2

—

101.8

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.0

1.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

5.2

—

44.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

0.0

5.2

—

25.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

110.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_XANTHELASMA and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_XANTHELASMA	1.022 [0.88, 1.19]	0.785
Birth year	0.991 [0.98, 1.0]	0.051

During the follow-up period (1.1.1998 — 31.12.2019), 206 out of 1522 females with H7_XANTHELASMA died.

Males

Parameter	HR [95% CI]	p-value
H7_XANTHELASMA	1.057 [0.87, 1.28]	0.572
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 633 males with H7_XANTHELASMA died.

Mortality risk

Mortality risk for people of age

years, who have H7_XANTHELASMA.

N-year risk	Females	Males
1	0.096%	0.197%
5	0.591%	1.24%
10	1.353%	3.169%
15	2.571%	6.058%
20	4.416%	9.757%

Relationships between endpoints

↥

Index endpoint: H7_XANTHELASMA – Xanthelasma of eyelid

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Xanthelasma of eyelid

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints